Is a complete TSX/FRX research report available?

No complete published report is available for tsx/FRX (TSX/FRX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/FRX (TSX/FRX)

Toronto Stock Exchange: TSX/FRX · CAD

CA$17.1

+0.00 (0.0%)· Recorded snapshot

Market cap	533.2M
Revenue (ttm)	84.1M
Net income (ttm)	-4.6M
EPS (ttm)	-CA$0.14
P/E (forward)	24.0x
Volume	15
Beta	1.07

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 84.1M
Net income (ttm): -4.6M
EPS (ttm): -CA$0.14
P/E (forward): 24.0x
Market cap: 533.2M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

All TSX/FRX indicators

Market & fundamental data

Available fields

186

Groups with data

Currency

USD

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	35
Employees Change	3%
Employees Change Percent	10.34
Enterprise value	CAD 476M
Exchange	Toronto Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA31447P1009
Last refreshed	2026-09-13
Market cap	CAD 533.2M
Price	CAD 17.1
Price currency	CAD
Rev Per Employee	2,402,849.77x
Sector	Healthcare
Sic	2836
Symbol	tsx/FRX
Website	https://www.fennecpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.87%
EV/Sales	5.79x
Forward P/E	24x
P/B ratio	8.85x
P/S ratio	6.34x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-1.9%
EBITDA Margin	-1.72%
Gross margin	93.73%
Gross Profit	CAD 78.8M
Gross Profit Growth	85.42%
Gross Profit Growth Q	97.5%
Gross Profit Growth3 Y	107.55%
Gross Profit Growth5 Y	218.26%
Net Income	CAD -4.6M
Net Income Growth Qo Q	881.59%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-5.24%
Profit Margin	-5.49%
Profit Per Employee	CAD -131,866
Profitable Quarters	CAD 2
ROA	-1.16
Roa5y	-25.84
ROCE	-1.77
ROE	-18.58
ROIC	-2.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	20.73%
Cagr15y	14.68%
Cagr1y	37.93%
Cagr20y	-3.14%
Cagr3y	16.16%
Cagr5y	11.33%
EPS Growth Qo Q	754.3
EPS Growth Quarters	2
EPS Growth Years	0
OCF Growth Qo Q	-97.9%
Revenue Growth	77.83x
Revenue Growth Q	85.18x
Revenue Growth Qo Q	18.31x
Revenue Growth Quarters	5x
Revenue Growth Years	0x
Revenue Growth3 Y	108.46x
Revenue Growth5 Y	222.41x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.98
Assets	CAD 107.6M
Cash	CAD 58.6M
Current Assets	CAD 100.5M
Current Liabilities	CAD 17.2M
Debt	CAD 0
Equity	CAD 60.3M
Interest Coverage	-1.19
Liabilities	CAD 47.3M
Long Term Assets	CAD 7.1M
Long Term Liabilities	CAD 30.1M
Net Cash	CAD 58.6M
Net Cash By Market Cap	CAD 10.99
Net Debt Equity	CAD -0.97
Tangible Book Value	CAD 60.3M
Tangible Book Value Per Share	CAD 1.72
WACC	10.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.85
Inventory Turnover	1.62
Net Working Capital	CAD 26.8M
Quick ratio	5.21
Working Capital	CAD 85.4M
Working Capital Turnover	CAD 1.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-16.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	557.69%
1Y total return	37.9%
200-day SMA	11.97
3Y total return	56.74%
50-day SMA	14.58
50-day SMA vs 200-day SMA	50over200
5Y total return	71%
All Time High	391.5
All Time High Change	-95.63%
All Time High Date	2001-06-05
All Time Low	0.27
All Time Low Change	6,233.33%
All Time Low Date	2008-12-09
ATR	0.68
Beta	1.07
Ch YTD	61.32
High	17.1
High52	17.64
High52 Date	2026-08-11
High52ch	-3.06%
Low	17.1
Low52	7.59
Low52 Date	2026-04-13
Low52ch	125.3%
Ma50ch	17.28%
Price vs 200-day SMA	42.89%
RSI	60.4
RSI Monthly	63.53
RSI Weekly	67.04
Sharpe ratio	1.03x
Sharpe Ratio3y	0.52x
Sharpe Ratio5y	0.51x
Sortino ratio	1.88
Sortino Ratio3y	0.83
Sortino Ratio5y	0.82
Total Return	-16.69%
Tr YTD	61.32
Tr15y	680.82%
Tr1m	6.74%
Tr1w	-1.1%
Tr3m	34.43%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19,880,595%
Net Borrowing	-26,996,095.9
Shares Insiders	2.91%
Shares Institutions	25.32%
Shares Qo Q	2.48%
Shares Yo Y	16.69%
Short Ratio	2.22

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted OCF	-13,229,847.3
Average Volume	1,119.1x
Bv Per Share	1.72
Ch10y	557.7
Ch15y	680.8
Ch1m	6.74
Ch1w	-1.1
Ch1y	37.9
Ch20y	-47.22
Ch3m	34.43
Ch3y	56.74
Ch5y	71
Ch6m	65.22
Change	0%
Change From Open	0
Close	17.1
Days Gap	0
Depreciation Amortization	142,301.6
Dollar Volume	256.5
Earnings Date	2026-11-12
EBIT	CAD -1.6M
EBITDA	CAD -1.5M
EPS	CAD -0.14
F Score	4
Financing CF	34,911,738
Fiscal Year End	December
Founded	1,996
Income Tax	CAD 210,175
Is Primary Listing	0
Last Earnings Date	2026-08-11
Last Report Date	2026-06-30
Last Split Date	2014-09-05
Last Split Type	Reverse
Ma150	11.95
Ma150ch	43.14%
Ma20	15.7
Ma20ch	8.9%
Net CF	32,014,734
Next Earnings Date	2026-11-12
Open	17.1
Price Date	2026-09-10
Ptbv Ratio	8.85
Relative Volume	0.01x
Revenue	84,099,742x
SBC By Revenue	12.67x
Share Based Comp	10,657,851
Tax By Revenue	0.25x
Tr20y	-47.22%
Tr6m	65.22%
Volume	15
Z Score	2.16

TSX/FRX (TSX/FRX)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/FRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/FRX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TSX/FRX

Frequently asked questions